
Max Hodak, co-founder of Neuralink and founder of Science, discusses the advancements and future of brain-computer interfaces (BCIs). Hodak details Science's retinal prosthesis, Prima, which restores sight by bypassing dead cells with a 2mm chip and laser-projected images, noting its potential approval later this year. The conversation explores BCI's role in restoring lost functionality, such as sight and motor control, and the potential for structural neural engineering to treat conditions like depression. Hodak emphasizes that BCI is a diverse field, akin to pharma, with various modalities like ultrasound for focus enhancement. He also touches on neuroplasticity, the brain's ability to adapt, and the unification of neuroscience and AI in understanding neural representations.
Sign in to continue reading, translating and more.
Continue